A detailed history of Ff Advisors,Llc transactions in Abb Vie Inc. stock. As of the latest transaction made, Ff Advisors,Llc holds 1,486 shares of ABBV stock, worth $287,570. This represents 0.18% of its overall portfolio holdings.

Number of Shares
1,486
Previous 1,486 -0.0%
Holding current value
$287,570
Previous $271 Million 5.81%
% of portfolio
0.18%
Previous 0.19%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 18, 2024

BUY
$159.82 - $182.1 $13,744 - $15,660
86 Added 6.14%
1,486 $271 Million
Q4 2023

Feb 14, 2024

BUY
$137.6 - $154.97 $192,640 - $216,958
1,400 New
1,400 $217 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $342B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Ff Advisors,Llc Portfolio

Follow Ff Advisors,Llc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ff Advisors,Llc, based on Form 13F filings with the SEC.

News

Stay updated on Ff Advisors,Llc with notifications on news.